1 – 10 of 18
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Molecular Markers and Hypoxia in Renal Cell Carcinoma
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2022
-
Mark
Size-based isolation and detection of renal carcinoma cells from whole blood
(
- Contribution to journal › Article
-
Mark
Mycotoxin Exposure and Renal Cell Carcinoma Risk : An Association Study in the EPIC European Cohort
(
- Contribution to journal › Article
- 2021
-
Mark
A Decision Analysis Evaluating Screening for Kidney Cancer Using Focused Renal Ultrasound
(
- Contribution to journal › Article
-
Mark
Prevalence, Disease-free, and Overall Survival of Contemporary Patients With Renal Cell Carcinoma Eligible for Adjuvant Checkpoint Inhibitor Trials
(
- Contribution to journal › Article
- 2020
-
Mark
Features of increased malignancy in eosinophilic clear cell renal cell carcinoma
(
- Contribution to journal › Article
-
Mark
Perivascular Neuropilin-1 expression is an independent marker of improved survival in renal cell carcinoma
(
- Contribution to journal › Article
- 2019
-
Mark
Long-term Outcomes of Follow-up for Initially Localised Clear Cell Renal Cell Carcinoma : RECUR Database Analysis
(
- Contribution to journal › Article
-
Mark
Intensive Imaging-based Follow-up of Surgically Treated Localised Renal Cell Carcinoma Does Not Improve Post-recurrence Survival : Results from a European Multicentre Database (RECUR)
(
- Contribution to journal › Letter
-
Mark
Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International Immunocancer Registry (ICIR)
(
- Contribution to journal › Article